ICTRP Search Portal

Main

Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.

Register:	ChiCTR
Last refreshed on:	18 April 2017
Main ID:	ChiCTR-IPC-14005625
Date of registration:	2014-12-03
Prospective Registration:	No
Primary sponsor:	The Affiliated Hospital of North Sichuan Medical College
Public title:	Randomized controlled study of proximal subtotal gastrectomy and total gastrectomy resection treatment for advanced adenocarcinoma of the esophagogastric junction (Siewert II)
Scientific title:	Randomized controlled study of proximal subtotal gastrectomy and total gastrectomy resection treatment for advanced adenocarcinoma of the esophagogastric junction (Siewert II)
Date of first enrolment:	2014-12-01
Target sample size:	1:50;2:50;
Recruitment status:	Recruiting
URL:	http://www.chictr.org.cn/showproj.aspx?proj=10018
Study type:	Interventional study
Study design:	Randomized parallel controlled trial
Phase:	II (Phase II study)

Countries of recruitment
China

Contacts

Name:	FU Mao-yong
Address:	Department of Cardiothoracic Surgery, The Affiliated Hospital of North Sichuan Medical College, Nanchong, China 637000
Telephone:	+86 13989186598
Email:	fumaoyongmd@163.com
Affiliation:

Name:	SHI Gui-dong
Address:	Department of Cardiothoracic Surgery, The Affiliated Hospital of North Sichuan Medical College, Nanchong, China 637000
Telephone:	+86 15182981861
Email:	shizhixiongdi@163.com
Affiliation:	The Affiliated Hospital of North Sichuan Medical College

Key inclusion & exclusion criteria

Inclusion criteria: 1) Advanced adenocarcinoma of esophagogastric junction (Siewert II);
2) Surgical pointer;
3) Proximal subtotal gastrectomy and total gastrectomy resection treatment is feasible;
4) informed patient.
Exclusion criteria: 1) Adenocarcinoma of esophagogastric junction (Siewert I or III);
2) Only with total gastrectomy to achieve R0 resection.

Age minimum: 30
Age maximum: 75
Gender: Both

Health Condition(s) or Problem(s) studied

C16.002

adenocarcinoma of esophagogastric junction

Intervention(s)

1:Proximate Gastrectomy ;2:Total Gastrectomy ;

Primary Outcome(s)

Survival time;Quality of Life;

Secondary Outcome(s)

Year recurrence rate after surgery;Mortality after one year;The incidence of postoperative complications;Operative mortality;

Secondary ID(s)

Source(s) of Monetary Support

North sichuan medical college project funds

Secondary Sponsor(s)

Ethics review

Results

Results available:
Date Posted:
Date Completed:
URL:

Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.